Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8993572
APP PUB NO 20130202692A1
SERIAL NO

13642652

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to particular substituted heterocycle fused gamma-carbolines of formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INTRA-CELLULAR THERAPIES, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Robert New York, US 203 3063
Li, Peng New York, US 818 7711
Mates, Sharon New York, US 50 1267
Tomesch, John Charles New York, US 12 468
Wennogle, Lawrence P New York, US 101 2132
Zhang, Qiang New York, US 707 4601

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00